ÂÜÀòÂÒÂ×

Isabelle B. has extensive work experience in regulatory affairs, spanning over two decades. Isabelle'smost recent position was as the Head of Regulatory Affairs at Inventiva Pharma, a role they began in November 2020. Prior to that, they worked as a Reg Affairs consultant freelancer, starting in January 2010.

Isabelle has also held various roles at GenSight Biologics. From November 2014 to September 2017, they served as the Director of Regulatory Affairs and QA. Isabelle then advanced to the position of Vice President of Regulatory Affairs and QA until July 2020.

Before GenSight Biologics, Isabelle worked at the Imagine Institute of Genetic Diseases. From October 2012 to October 2014, they worked as the Head of Regulatory Affairs for Gene Therapy, overseeing regulatory submissions and managing collaborations with industrial partners.

Isabelle also gained experience at Bioprojet, serving as the Head of Regulatory Affairs from May 2011 to October 2012. In this role, they managed regulatory submissions and provided regulatory strategy advice for a new chemical entity for an orphan neurologic disease.

Isabelle started their career at Biogen in April 2001, where they held the position of Senior Pharmacist Regulatory Affairs for International Biologics/INF beta/multiple sclerosis until October 2004.

Throughout their career, Isabelle has demonstrated expertise in regulatory submissions, regulatory strategy, and managing collaborations with regulatory authorities and external stakeholders.

Isabelle B. completed their Doctorate of Pharmacy (PharmD) at Université Paris-Saclay from 1987 to 1995. Isabelle then pursued a Ph.D. in Chemistry, specializing in Pharmacology Chemistry, at the same university from 1994 to 1998.